Publication | Open Access
Novel 4,5-Dihydro-thiazinogeldanamycin in a<i>gdmP</i>Mutant Strain of<i>Streptomyces hygroscopicus</i>17997
10
Citations
0
References
2011
Year
EngineeringGdmp MutantAntimicrobial ChemotherapyPharmaceutical ChemistryDrug ResistanceMedicinal ChemistryBiosynthesisNatural Product BiosynthesisAntimicrobial ResistanceGeldanamycin BiosynthesisAntimicrobial Drug DiscoveryBiochemistryNovel Geldanamycin DerivativeAntimicrobial CompoundNovel 4,5-Dihydro-thiazinogeldanamycinClinical MicrobiologySynthetic BiologyMicrobiologyMedicine
Novel geldanamycin derivative, 4,5-dihydro-thiazinogeldanamycin (3), was characterized from the gdmP mutant in Streptomyces hygroscopicus 17997, besides expected 4,5-dihydro-geldanamycin (2). The presence of this compound would suggest an unknown post-PKS modification in geldanamycin biosynthesis. Compound 3 exhibited moderate anti-HSV-1-virus activity and higher water solubility than geldanamycin (1). Cysteine served as a precursor to synthesize 3, whose formation required obligatory enzymatic assistance.